Neuro-bioenergetic concepts in cancer prevention and treatment

Medical Hypotheses

Volumn 68, Issue 4, 2007, Pages 832-843

  Hoang, Ba X ^a   Graeme Shaw, D ^a   Pham, Phuong ^a   Levine, Stephen A ^a  

^a Allergy Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; AMPA RECEPTOR ANTAGONIST; BACLOFEN; CAFFEINE; CARCINOGEN; DIZOCILPINE; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FOLIC ACID; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; GLYCINE; GYK 152466; GYK I52466; ICOSAPENTAENOIC ACID; MAGNESIUM; MATRINE; MATRIX METALLOPROTEINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NITRIC OXIDE; OMEGA 3 FATTY ACID; OXYMATRINE; SOMATOMEDIN; THEOBROMINE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOENERGY; CANCER; CANCER PREVENTION; COLON TUMOR; DRUG MEGADOSE; ENZYME ACTIVATION; HUMAN; LIVER TUMOR; LUNG CANCER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ACETYLCHOLINE; ANTINEOPLASTIC AGENTS; CARCINOGENS; FATTY ACIDS; GLUTAMIC ACID; HUMANS; MAGNESIUM; MUTATION; N-METHYLASPARTATE; NEOPLASMS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; RECEPTORS, PURINERGIC P1; SODIUM CHANNELS; SOMATOMEDINS;

EID: 33846413914     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.09.005     Document Type: Article

References (124)

1. Kwon S.J., and Lee Y.J. Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells. Clin Cancer Res 11 (2005) 4694-4700
2. Papp-Szabo E., Josephy P.D., and Coomber B.L. Microenvironmental influences on mutagenesis in mammary epithelial cells. Int J Cancer 116 (2005) 679-685
3. Hoang BX, Levin SA, Pham P, Shaw DG. Hypothesis of the cause and development of neoplasms. Eur J Cancer Prevention, in press.
4. Hoang B.X., Levine S.A., Graeme Shaw D., Pham P., and Hoang C. Bronchial epilepsy or broncho-pulmonary hyper-excitability as a model of asthma pathogenesis. Med Hypotheses (2006)
5. + channels: multiplicity of expression, plasticity, functional implications and pathophysiological aspects. Eur Biophys J 33 (2004) 180-193
6. O'Grady S.M., and Lee S.Y. Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. Int J Biochem Cell Biol 37 (2005) 1578-1594
7. + channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol 150 (1997) 1213-1221
8. + channel activity. J Cell Sci 114 (2001) 2697-2705
9. + channels confer invasive properties on human prostate cancer cells. Pflugers Arch 447 (2004) 908-914
10. Roger S., Besson P., and Le Guennec J.Y. Involvement of a novel fast inward sodium current in the invasion capacity of a breast cancer cell line. Biochim Biophys Acta 1616 (2003) 107-111
11. Blandino J.K., Viglione M.P., Bradley W.A., Oie H.K., and Kim Y.I. Voltage-dependent sodium channels in human small-cell lung cancer cells: role in action potentials and inhibition by Lambert-Eaton syndrome IgG. J Membr Biol 143 (1995) 153-163
12. Onganer P.U., and Djamgoz M.B. Small-cell lung cancer (human): potentiation of endocytic membrane activity by voltage-gated Na(+) channel expression in vitro. J Membr Biol 204 (2005) 67-75
13. Onganer P.U., Seckl M.J., and Djamgoz M.B. Neuronal characteristics of small-cell lung cancer. Br J Cancer 93 (2005) 1197-1201
14. + channels and the intracellular calcium signal in human melanoma cell proliferation. J Membr Biol 151 (1996) 149-157
15. Champigny G., Verrier B., and Lazdunski M. A voltage, calcium, and ATP sensitive non selective cation channel in human colonic tumor cells. Biochem Biophys Res Commun 176 (1991) 1196-1203
16. Fraser S.P., Diss J.K., Chioni A.M., et al. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res 11 (2005) 5381-5389
17. Glassmeier G., Strubing C., Riecken E.O., et al. Electrophysiological properties of human carcinoid cells of the gut. Gastroenterology 113 (1997) 90-100
18. Dang K., Bielfeldt K., Lamb K., and Gebhart G.F. Gastric ulcers evoke hyperexcitability and enhance P2X receptor function in rat gastric sensory neurons. J Neurophysiol 93 (2005) 3112-3119
19. + channels in comparison with those of procaine. Sheng Li Xue Bao 50 (1998) 145-152
20. Sikes R.A., Walls A.M., Brennen W.N., et al. Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockers. Clin Prostate Cancer 2 (2003) 181-187
21. Fraser S.P., Ding Y., Liu A., Foster C.S., and Djamgoz M.B. Tetrodotoxin suppresses morphological enhancement of the metastatic MAT-LyLu rat prostate cancer cell line. Cell Tissue Res 295 (1999) 505-512
22. Jude S., Roger S., Martel E., et al. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. Prog Biophys Mol Biol 90 (2006) 299-325
23. + channel. Proc Natl Acad Sci USA 95 (1998) 2680-2685
24. Curtis D.R., and Watkins J.C. Acidic amino acids with strong excitatory actions on mammalian neurones. J Physiol 166 (1963) 1-14
25. Olney J.W. Heritable disorders of amino acid metabolism. In: Nyhan W.N. (Ed) (1974), Wiley, New York 501-512
26. Zipfel G.J., Lee J.M., and Choi D.W. Reducing calcium overload in the ischemic brain. N Engl J Med 341 (1999) 1543-1544
27. Price D.L. New order from neurological disorders. Nature 399 (1999) A3-A5
28. Smith T., Groom A., Zhu B., and Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6 (2000) 62-66
29. Cavalheiro E.A., and Olney J.W. Glutamate antagonists: deadly liaisons with cancer. Proc Natl Acad Sci USA 98 (2001) 5947-5948
30. Ye Z.C., and Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59 (1999) 4383-4391
31. Abdul M., and Hoosein N. N-methyl-d-aspartate receptor in human prostate cancer. J Membr Biol 205 (2005) 125-128
32. Stepulak A., Sifringer M., Rzeski W., et al. NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci USA 102 (2005) 15605-15610
33. Rzeski W., Turski L., and Ikonomidou C. Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 98 (2001) 6372-6377
34. Gallo V., Pende M., Scherer S., Molne M., and Wright P. Expression and regulation of kainate and AMPA receptors in uncommitted and committed neural progenitors. Neurochem Res 20 (1995) 549-560
35. Bardoul M., Levallois C., and Konig N. Functional AMPA/kainate receptors in human embryonic and foetal central nervous system. J Chem Neuroanat 14 (1998) 79-85
36. Iwata M., Komori S., Unno T., Minamoto N., and Ohashi H. Modification of membrane currents in mouse neuroblastoma cells following infection with rabies virus. Br J Pharmacol 126 (1999) 1691-1698
37. Celli A., Treves C., Nassi P., and Stio M. Role of 1,25-dihydroxyvitamin D3 and extracellular calcium in the regulation of proliferation in cultured SH-SY5Y human neuroblastoma cells. Neurochem Res 24 (1999) 691-698
38. Clapham D.E. Calcium signaling. Cell 80 (1995) 259-268
39. Gomez T.M., and Spitzer N.C. In vivo regulation of axon extension and pathfinding by growth-cone calcium transients. Nature 397 (1999) 350-355
40. Lafon-Cazal M., Pietri S., Culcasi M., and Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 364 (1993) 535-537
41. Lafon-Cazal M., Culcasi M., Gaven F., Pietri S., and Bockaert J. Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology 32 (1993) 1259-1266
42. Coyle J.T., and Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262 (1993) 689-695
43. Kim Y., Min H.Y., Park H.J., et al. Suppressive effects of nitric oxide production and inducible nitric oxide synthase (iNOS) gene expression by Calystegia soldanella methanol extract on lipopolysaccharide-activated RAW 264.7 cells. Eur J Cancer Prev 13 (2004) 419-424
44. Cocco P., Kazerouni N., and Zahm S.H. Cancer mortality and environmental exposure to DDE in the United States. Environ Health Perspect 108 (2000) 1-4
45. Ji B.T., Silverman D.T., Stewart P.A., et al. Occupational exposure to pesticides and pancreatic cancer. Am J Ind Med 39 (2001) 92-99
46. Li D. Molecular epidemiology of pancreatic cancer. Cancer J 7 (2001) 259-265
47. Rice J.M. The carcinogenicity of acrylamide. Mutat Res 580 (2005) 3-20
48. Lynge E., Anttila A., and Hemminki K. Organic solvents and cancer. Cancer Causes Control 8 (1997) 406-419
49. Nelson R.A., Levine A.M., Marks G., and Bernstein L. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma. Br J Cancer 76 (1997) 1532-1537
50. Belousov A.B., O'Hara B.F., and Denisova J.V. Acetylcholine becomes the major excitatory neurotransmitter in the hypothalamus in vitro in the absence of glutamate excitation. J Neurosci 21 (2001) 2015-2027
51. McLean R.M. Magnesium and its therapeutic uses: a review. Am J Med 96 (1994) 63-76
52. Tence M., Murphy N., Cordier J., Premont J., and Glowinski J. Synergistic effects of acetylcholine and glutamate on the release of arachidonic acid from cultured striatal neurons. J Neurochem 64 (1995) 1605-1613
53. Fu W.M., Liou J.C., Lee Y.H., and Liou H.C. Potentiation of neurotransmitter release by activation of presynaptic glutamate receptors at developing neuromuscular synapses of Xenopus. J Physiol 489 Pt 3 (1995) 813-823
54. Montenegro M.F., Nieto-Ceron S., Ruiz-Espejo F., Paez de la Cadena M., Rodriguez-Berrocal F.J., and Vidal C.J. Cholinesterase activity and enzyme components in healthy and cancerous human colorectal sections. Chem Biol Interact 157-158 (2005) 429-430
55. Martinez-Moreno P., Nieto-Ceron S., Torres-Lanzas J., et al. Cholinesterase activity of human lung tumours varies according to their histological classification. Carcinogenesis 27 (2006) 429-436
56. Minna J.D. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J Clin Invest 111 (2003) 31-33
57. Song P., Sekhon H.S., Proskocil B., Blusztajn J.K., Mark G.P., and Spindel E.R. Synthesis of acetylcholine by lung cancer. Life Sci 72 (2003) 2159-2168
58. Ukegawa J.I., Takeuchi Y., Kusayanagi S., and Mitamura K. Growth-promoting effect of muscarinic acetylcholine receptors in colon cancer cells. J Cancer Res Clin Oncol 129 (2003) 272-278
59. Yang Y.Y., Koh L.W., Tsai J.H., et al. Involvement of viral and chemical factors with oral cancer in Taiwan. Jpn J Clin Oncol 34 (2004) 176-183
60. Ortega A. A new role for GABA: inhibition of tumor cell migration. Trends Pharmacol Sci 24 (2003) 151-154
61. Tatsuta M., Iishi H., Baba M., and Taniguchi H. Attenuation by the GABA receptor agonist baclofen of experimental carcinogenesis in rat colon by azoxymethane. Oncology 49 (1992) 241-245
62. Gundersen R.Y., Vaagenes P., Breivik T., Fonnum F., and Opstad P.K. Glycine-an important neurotransmitter and cytoprotective agent. Acta Anaesthesiol Scand 49 (2005) 1108-1116
63. Rose M.L., Cattley R.C., Dunn C., Wong V., Li X., and Thurman R.G. Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643. Carcinogenesis 20 (1999) 2075-2081
64. Rose M.L., Madren J., Bunzendahl H., and Thurman R.G. Dietary glycine inhibits the growth of B16 melanoma tumors in mice. Carcinogenesis 20 (1999) 793-798
65. Yamashina S., Konno A., Wheeler M.D., et al. Endothelial cells contain a glycine-gated chloride channel. Nutr Cancer 40 (2001) 197-204
66. Ikejima K., Iimuro Y., Forman D.T., and Thurman R.G. A diet containing glycine improves survival in endotoxin shock in the rat. Am J Physiol 271 (1996) G97-G103
67. Barker J.L. GABA and glycine: ion channel mechanisms. In: Rogawski M.A., and Barker J.L. (Eds). Neurotransmitter actions in the vertebrate nervous system (1985), Plenum Press, New York 71-100
68. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
69. Lipton S.A., and Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330 (1994) 613-622
70. Cooper J., Bloom F., and Roth R. The biochemical basis of neuropharmacology (1997), Oxford University Press, Santa Fe
71. Furukawa Y., and Chiba S. Effects of magnesium on the isolated, blood-perfused atrial and ventricular preparations of the dog heart. Jpn Heart J 22 (1981) 239-246
72. 2+ concentrations on cardiac electrophysiologic parameters. Cardiovasc Drugs Ther 3 (1989) 183-189
73. Wolf F.I., Maier J.A., Nasulewicz A., et al. Magnesium and neoplasia: From carcinogenesis to tumor growth and progression or treatment. Arch Biochem Biophys (2006)
74. Leone N., Courbon D., Ducimetiere P., and Zureik M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology 17 (2006) 308-314
75. Larsson S.C., Bergkvist L., and Wolk A. Magnesium intake in relation to risk of colorectal cancer in women. Jama 293 (2005) 86-89
76. Larsson S.C., Kumlin M., Ingelman-Sundberg M., and Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79 (2004) 935-945
77. Schley P.D., Jijon H.B., Robinson L.E., and Field C.J. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 92 (2005) 187-195
78. Bagga D., Anders K.H., Wang H.J., and Glaspy J.A. Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer. Nutr Cancer 42 (2002) 180-185
79. Tsai W.S., Nagawa H., Kaizaki S., Tsuruo T., and Muto T. Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants. J Gastroenterol 33 (1998) 206-212
80. Astorg P. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 15 (2004) 367-386
81. Vreugdenhil M., Bruehl C., Voskuyl R.A., Kang J.X., Leaf A., and Wadman W.J. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci USA 93 (1996) 12559-12563
82. Zieminska E., Stafiej A., and Lazarewicz J.W. Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurones. Neurochem Int 43 (2003) 481-492
83. Weinstein S.J., Ziegler R.G., Selhub J., et al. Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control 12 (2001) 317-324
84. Martinez M.E., Henning S.M., and Alberts D.S. Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence. Am J Clin Nutr 79 (2004) 691-697
85. Giovannucci E., Stampfer M.J., Colditz G.A., et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129 (1998) 517-524
86. Pellerin L., and Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91 (1994) 10625-10629
87. Krnjevic K. Early effects of hypoxia on brain cell function. Croat Med J 40 (1999) 375-380
88. Magistretti P.J., Pellerin L., Rothman D.L., and Shulman R.G. Energy on demand. Science 283 (1999) 496-497
89. Sibson N.R., Dhankhar A., Mason G.F., Rothman D.L., Behar K.L., and Shulman R.G. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci USA 95 (1998) 316-321
90. + load and oxidative stress in nerve terminals: relevance to ischemia/reperfusion. J Neurochem 83 (2002) 855-862
91. Jadeski L.C., Chakraborty C., and Lala P.K. Role of nitric oxide in tumour progression with special reference to a murine breast cancer model. Can J Physiol Pharmacol 80 (2002) 125-135
92. Tavares Murta B.M., Machado J.S., Zaparoli M., Lara V.C., and Murta E.F. The relationship of host immune cells, cytokine and nitric oxide production to tumor cells in ovarian carcinoma. Sao Paulo Med J 117 (1999) 87-92
93. Zhao X., Liu S.J., Zhang J., Strong R., Aronowski J., and Grotta J.C. Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats. Stroke 36 (2005) 129-134
94. Vincent A.M., Mobley B.C., Hiller A., and Feldman E.L. IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis 16 (2004) 407-416
95. Leski M.L., Valentine S.L., Baer J.D., and Coyle J.T. Insulin-like growth factor I prevents the development of sensitivity to kainate neurotoxicity in cerebellar granule cells. J Neurochem 75 (2000) 1548-1556
96. Holly J.M., Gunnell D.J., and Davey Smith G. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?. J Endocrinol 162 (1999) 321-330
97. Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 (1998) 563-566
98. Hankinson S.E., Willett W.C., Colditz G.A., et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396
99. Ma J., Pollak M.N., Giovannucci E., et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91 (1999) 620-625
100. Pollak M.N., Schernhammer E.S., and Hankinson S.E. Insulin-like growth factors and neoplasia. Nat Rev Cancer 4 (2004) 505-518
101. Cappuzzo F., Toschi L., Tallini G., et al. Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib. Ann Oncol 17 (2006) 1120-1127
102. Ahlen J., Wejde J., Brosjo O., et al. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma. Clin Cancer Res 11 (2005) 206-216
103. Folgueras A.R., Pendas A.M., Sanchez L.M., and Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48 (2004) 411-424
104. Manabe S., Gu Z., and Lipton S.A. Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 46 (2005) 4747-4753
105. Zhang X., Cheng M., and Chintala S.K. Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest Ophthalmol Vis Sci 45 (2004) 2374-2383
106. Mujoomdar M., Hoskin D., and Blay J. Adenosine stimulation of the proliferation of colorectal carcinoma cell lines. Roles of cell density and adenosine metabolism. Biochem Pharmacol 66 (2003) 1737-1747
107. Mujoomdar M., Bennett A., Hoskin D., and Blay J. Adenosine stimulation of proliferation of breast carcinoma cell lines: evaluation of the [3H]thymidine assay system and modulatory effects of the cellular microenvironment in vitro. J Cell Physiol 201 (2004) 429-438
108. Linden J. Adenosine metabolism and cancer. Am J Physiol Cell Physiol (2006)
109. Barcz E., Sommer E., Janik P., Marianowski L., and Skopinska-Rozewska E. Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells. Oncol Rep 7 (2000) 1285-1291
110. Hayashi M., Tsuchiya H., Yamamoto N., et al. Caffeine-potentiated chemotherapy for metastatic carcinoma and lymphoma of bone and soft tissue. Anticancer Res 25 (2005) 2399-2405
111. Yang H., Rouse J., Lukes L., et al. Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis. Clin Exp Metastasis 21 (2004) 719-735
112. Gude R.P., Menon L.G., and Rao S.G. Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells. J Exp Clin Cancer Res 20 (2001) 287-292
113. Lu Y.P., Lou Y.R., Xie J.G., et al. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA 99 (2002) 12455-12460
114. Oba S., Shimizu N., Nagata C., et al. The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer Lett (2006)
115. Baker J.A., Beehler G.P., Sawant A.C., Jayaprakash V., McCann S.E., and Moysich K.B. Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 136 (2006) 166-171
116. Kurozawa Y., Ogimoto I., Shibata A., et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 93 (2005) 607-610
117. Young H.W., Molina J.G., Dimina D., et al. A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice. J Immunol 173 (2004) 1380-1389
118. Fozard J.R. The case for a role for adenosine in asthma: almost convincing?. Curr Opin Pharmacol 3 (2003) 264-269
119. Chan E.S., Montesinos M.C., Fernandez P., et al. Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol (2006)
120. + channels in hypoxia-induced neuronal injuries. Clin Exp Pharmacol Physiol 27 (2000) 569-574
121. Novelli A., Reilly J.A., Lysko P.G., and Henneberry R.C. Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced. Brain Res 451 (1988) 205-212
122. Turski L., and Turski W.A. Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology. Experientia 49 (1993) 1064-1072
123. Rapaport E., and Fontaine J. Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools. Proc Natl Acad Sci USA 86 (1989) 1662-1666
124. Anway M.D., Cupp A.S., Uzumcu M., and Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308 (2005) 1466-1469